메뉴 건너뛰기




Volumn 28, Issue 4, 2004, Pages 266-274

Therapeutic interchange of drugs not included in the hospital's pharmacotherapeutic guide: A quality program;Programa de calidad aplicado a la sustitución de medicamentos no incluidos en la guía farmacoterapéutica del hospital

Author keywords

Drug formulary; Drug substitution; Quality assessment; Quality indicators; Therapeutic interchange

Indexed keywords

ARTICLE; DRUG COST; DRUG FORMULARY; DRUG PROGRAM; DRUG QUALITY; DRUG SUBSTITUTION; ERROR; GENERAL HOSPITAL; HOSPITAL PHARMACY; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PHARMACY AND THERAPEUTICS COMMITTEE; PRESCRIPTION; PREVALENCE; PROCESS MONITORING; THERAPEUTIC DRUG INTERCHANGE;

EID: 4644266218     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (23)
  • 2
    • 0037083292 scopus 로고    scopus 로고
    • Use of patient's own medications in small hospitals
    • Pamela E. Norstrom and Carolyn M. Brown. Use of patient's own medications in small hospitals. Am J Health-Syst Pharm 2002; 59: 349-54.
    • (2002) Am J Health-Syst Pharm , vol.59 , pp. 349-354
    • Norstrom, P.E.1    Brown, C.M.2
  • 3
    • 0034303272 scopus 로고    scopus 로고
    • Therapeutic interchange of low-molecular-weight heparins
    • Burnakis TG. Therapeutic interchange of low-molecular-weight heparins. Am J Health-Syst Pharm 2000; 57: 1797-8.
    • (2000) Am J Health-Syst Pharm , vol.57 , pp. 1797-1798
    • Burnakis, T.G.1
  • 4
    • 0035799243 scopus 로고    scopus 로고
    • Ética de la prescripción. Conflictos del médico con el paciente, la entidad gestora y la industria farmacéutica
    • Martín Moreno S. Ética de la prescripción. Conflictos del médico con el paciente, la entidad gestora y la industria farmacéutica. Med Clin 2001; 116: 299-306.
    • (2001) Med Clin , vol.116 , pp. 299-306
    • Martín Moreno, S.1
  • 5
    • 0036139536 scopus 로고    scopus 로고
    • Pharmacist scope of practice
    • Keely JL. Pharmacist scope of practice. Ann Intern Med 2002; 136: 79-85.
    • (2002) Ann Intern Med , vol.136 , pp. 79-85
    • Keely, J.L.1
  • 6
    • 18344407023 scopus 로고    scopus 로고
    • Riesgo sanitario y errores de medicación
    • Montojo Guillén C. Riesgo sanitario y errores de medicación. Farm Hosp 2000; 24: 348-55.
    • (2000) Farm Hosp , vol.24 , pp. 348-355
    • Montojo Guillén, C.1
  • 7
    • 0034959895 scopus 로고    scopus 로고
    • Illegible prescription hand writing. Blanket medication orders. "Range" medication orders. Automatic stop orders
    • Rich DS. Illegible prescription hand writing. Blanket medication orders. "Range" medication orders. Automatic stop orders. Hosp Pharm 2001; 36: 786-9.
    • (2001) Hosp Pharm , vol.36 , pp. 786-789
    • Rich, D.S.1
  • 8
    • 0036145647 scopus 로고    scopus 로고
    • Automatic interchange of the ACE inhibitors: Decision-making process and initial results
    • Stoysich A, Massoomi F. Automatic interchange of the ACE inhibitors: decision-making process and initial results. Formulary 2002; 37: 41-4.
    • (2002) Formulary , vol.37 , pp. 41-44
    • Stoysich, A.1    Massoomi, F.2
  • 9
    • 0034926139 scopus 로고    scopus 로고
    • Evaluación de un programa de atención farmacéutica en unidades de hospitalización con dispensación individualizada de medicamentos en dosis unitarias
    • Carmona García PM, García Cortés E, Font I. Evaluación de un programa de atención farmacéutica en unidades de hospitalización con dispensación individualizada de medicamentos en dosis unitarias. Farm Hosp 2001; 25: 156-63.
    • (2001) Farm Hosp , vol.25 , pp. 156-163
    • Carmona García, P.M.1    García Cortés, E.2    Font, I.3
  • 10
    • 0033750810 scopus 로고    scopus 로고
    • Acontecimientos adversos por medicamentos: Una patología emergente
    • Otero MJ, Domínguez Gil A. Acontecimientos adversos por medicamentos: una patología emergente. Farm Hosp 2000; 24: 258-66.
    • (2000) Farm Hosp , vol.24 , pp. 258-266
    • Otero, M.J.1    Domínguez Gil, A.2
  • 11
    • 0035186902 scopus 로고    scopus 로고
    • Pharmacy issues: Formulary changes and allergy checking
    • Miller AS. Pharmacy issues: formulary changes and allergy checking. Hosp Pharm 2001; 36: 1209-13.
    • (2001) Hosp Pharm , vol.36 , pp. 1209-1213
    • Miller, A.S.1
  • 12
    • 4644290325 scopus 로고    scopus 로고
    • Criterios de calidad en la sustitución de medicamentos no incluidos en la Guía Farmacoterapéutica
    • Valencia. Octubre
    • González P, San Martín E, Font I, Navarro S. Criterios de calidad en la sustitución de medicamentos no incluidos en la Guía Farmacoterapéutica. XLVI Congreso Nacional de la SEFH. Valencia. Octubre 2001.
    • (2001) XLVI Congreso Nacional de la SEFH
    • González, P.1    San Martín, E.2    Font, I.3    Navarro, S.4
  • 15
    • 0033917930 scopus 로고    scopus 로고
    • Programa para la sustitución de equivalentes terapéuticos en el medio hospitalario
    • Delgado Sánchez O, Puigventó Latorre F, Llodrá Ortola V. Programa para la sustitución de equivalentes terapéuticos en el medio hospitalario. Rev Clin Esp 2000; 200: 261-70.
    • (2000) Rev Clin Esp , vol.200 , pp. 261-270
    • Delgado Sánchez, O.1    Puigventó Latorre, F.2    Llodrá Ortola, V.3
  • 16
    • 0034081029 scopus 로고    scopus 로고
    • Strategies for therapeutic interchange of biotechnology medicines: Proceedings of an invitational conference
    • Bergstrom K, Ellis M. Strategies for therapeutic interchange of biotechnology medicines: proceedings of an invitational conference. Hosp Pharm 2000; 35: 377-92.
    • (2000) Hosp Pharm , vol.35 , pp. 377-392
    • Bergstrom, K.1    Ellis, M.2
  • 17
    • 0035182357 scopus 로고    scopus 로고
    • Legal issues surrounding therapeutic interchange in institutional settings: An update
    • Brushwood DB. Legal issues surrounding therapeutic interchange in institutional settings: an update. Formulary 2001; 36: 796-804.
    • (2001) Formulary , vol.36 , pp. 796-804
    • Brushwood, D.B.1
  • 18
    • 0037086314 scopus 로고    scopus 로고
    • Survey of hospital policies regarding low-molecular-weight heparins
    • Schumock GT, Nutescu EA. Survey of hospital policies regarding low-molecular-weight heparins. Am J Health-Syst Pharm 2002; 59: 534-8.
    • (2002) Am J Health-Syst Pharm , vol.59 , pp. 534-538
    • Schumock, G.T.1    Nutescu, E.A.2
  • 19
    • 0035036463 scopus 로고    scopus 로고
    • Patient-perceived outcomes of an inpatient PPI therapeutic interchange program
    • Galt KA, Galt MA, Sodorff MM. Patient-Perceived outcomes of an inpatient PPI therapeutic interchange program. Formulary 2001; 36: 340-54.
    • (2001) Formulary , vol.36 , pp. 340-354
    • Galt, K.A.1    Galt, M.A.2    Sodorff, M.M.3
  • 20
    • 0037086313 scopus 로고    scopus 로고
    • Prevalence and cost savings of therapeutic interchange among US hospitals
    • Schachtner JM, Guharoy R, Medicis JJ, et al. Prevalence and cost savings of therapeutic interchange among US hospitals. Am J Health-Syst Pharm 2002; 59: 529-33.
    • (2002) Am J Health-Syst Pharm , vol.59 , pp. 529-533
    • Schachtner, J.M.1    Guharoy, R.2    Medicis, J.J.3
  • 21
    • 0034658595 scopus 로고    scopus 로고
    • Pharmacist's perceptions of a therapeutic-interchange program
    • Sodorff MM, Galt KA, Galt MA. Pharmacist's perceptions of a therapeutic-interchange program. Am J Health-Syst Pharm 2000; 57: 999-1000.
    • (2000) Am J Health-Syst Pharm , vol.57 , pp. 999-1000
    • Sodorff, M.M.1    Galt, K.A.2    Galt, M.A.3
  • 22
    • 0030479132 scopus 로고    scopus 로고
    • Sustitución y selección de equivalentes terapéuticos
    • Boix Montañes A, Barrera Puigdollers MT. Sustitución y selección de equivalentes terapéuticos. Farm Hosp 1996; 20: 351-8.
    • (1996) Farm Hosp , vol.20 , pp. 351-358
    • Boix Montañes, A.1    Barrera Puigdollers, M.T.2
  • 23
    • 0034192304 scopus 로고    scopus 로고
    • Therapeutic interchange in community pharmacies in Virginia
    • Carroll NV. Therapeutic interchange in community pharmacies in Virginia. Am J Health-Syst Pharm 2000; 57: 882-6.
    • (2000) Am J Health-Syst Pharm , vol.57 , pp. 882-886
    • Carroll, N.V.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.